A rationally designed peptide IA-2-P2 against type 1 diabetes in streptozotocin-induced diabetic mice

被引：3

作者：

Shen, Lili ^{[1
]}

Lu, Shiping ^{[1
]}

Huang, Dongcheng ^{[1
]}

Li, Guoliang ^{[1
]}

Liu, Kunfeng ^{[1
]}

Cao, Rongyue ^{[1
]}

Zong, Li ^{[2
]}

Jin, Liang ^{[1
]}

Wu, Jie ^{[1
]}

机构：

[1] China Pharmaceut Univ, Sch Life Sci & Technol, Minigene Pharm Lab, Nanjing 210000, Peoples R China

[2] China Pharmaceut Univ, Inst Pharmaceut, Sch Pharm, Nanjing, Jiangsu, Peoples R China

来源：

DIABETES & VASCULAR DISEASE RESEARCH | 2017年 / 14卷 / 03期

基金：

中国国家自然科学基金;

关键词：

Type; 1; diabetes; peptide P277; insulinoma antigen-2; atherosclerosis; HEAT-SHOCK-PROTEIN; BETA-CELL FUNCTION; PHASE-II TRIAL; DOUBLE-BLIND; DIAPEP277; VACCINATION; THERAPY; ATHEROSCLEROSIS; AUTOANTIGEN; MELLITUS;

D O I：

10.1177/1479164116664189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies have investigated the potential of type 1 diabetes mellitus-related autoantigens, such as heat shock protein 60, to induce immunological tolerance or to suppress the immune response. A functional 24-residue peptide derived from heat shock protein 60 (P277) has shown anti-type 1 diabetes mellitus potential in experimental animals and in clinical studies, but it also carries a potential atherogenic effect. In this study, we have modified P277 to retain an anti-type 1 diabetes mellitus effect and minimize the atherogenic potential by replacing the P277 B epitope with another diabetes-associated autoantigen, insulinoma antigen-2 (IA-2), to create the fusion peptide IA-2-P2. In streptozotocin-induced diabetic C57BL/6J mice, the IA-2-P2 peptide displayed similar anti-diabetic effects to the control P277 peptide. Also, the IA-2-P2 peptide did not show atherogenic activity in a rabbit model. Our findings indicate the potential of IA-2-P2 as a promising vaccine against type 1 diabetes mellitus.

引用

页码：184 / 190

页数：7

共 25 条

[11] Immunization with P277 induces vascular leak syndrome in C57BL/6 mice via endothelial damage [J].

Lu Yong ;

Sun Yunxiao ;

Xiong Qiyan ;

Zhang Yu ;

Hou Jing ;

Mekoo, Didier J. L. ;

Zhang Fan ;

Hu Xiangbing ;

Ma Yanjun ;

Liu Jingjing ;

Li Taiming .

AUTOIMMUNITY, 2010, 43 (08) :654-663

[12] Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus [J].

Ma, Yan-Jun ;

Lu, Yong ;

Hou, Jing ;

Dong, Yuan-Kai ;

Du, Ming-Zhu ;

Xing, Yun ;

Ge, Chi-Yu ;

Xu, Mao-Lei ;

Jin, Liang ;

Cao, Rong-Yue ;

Li, Tai-Ming ;

Wu, Jie ;

Liu, Jing-Jing .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (09) :1298-1302

[13]

Nicholas D, 2011, DISCOV MED, V11, P293

[14] Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis [J].

Nussbaum, Gabriel ;

Zanin-Zhorov, Alexandra ;

Quintana, Francisco ;

Lider, Ofer ;

Cohen, Irun R. .

INTERNATIONAL IMMUNOLOGY, 2006, 18 (10) :1413-1419

[15] Heat shock proteins, inflammation, and cardiovascular disease [J].

Pockley, AG .

CIRCULATION, 2002, 105 (08) :1012-1017

[16] Clinical Update on the Use of Immuno Modulators (antiCD3, GAD, Diapep277, Anti-IL1) in Type 1 Diabetes [J].

Pozzilli, Paolo ;

Guglielmi, Chiara ;

Maggi, Daria ;

Carlone, Angela ;

Buzzetti, Raffaella ;

Manfrini, Silvia .

CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (29) :3224-3228

[17] Treatment of new-onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta-cell function:: extension of a randomized, double-blind, phase II trial [J].

Raz, I. ;

Avron, A. ;

Tamir, M. ;

Metzger, M. ;

Symer, L. ;

Eldor, R. ;

Cohen, I. R. ;

Elias, D. .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (04) :292-298

[18] β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277):: a randomised, double-blind, phase II trial [J].

Raz, I ;

Elias, D ;

Avron, A ;

Tamir, M ;

Metzger, M ;

Cohen, IR .

LANCET, 2001, 358 (9295) :1749-1753

[19] Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2 [J].

Seissler, J ;

Schott, M ;

Morgenthaler, NG ;

Scherbaum, WA .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (02) :157-163

[20] Antigen-Based Therapy for the Treatment of Type 1 Diabetes [J].

Tian, Jide ;

Kaufman, Daniel L. .

DIABETES, 2009, 58 (09) :1939-1946

← 1 2 3 →